| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5657431 | Clinical Gastroenterology and Hepatology | 2017 | 33 Pages |
Abstract
In this prospective cohort study, we found no association between maternal thiopurine use during pregnancy and increased spontaneous abortions, adverse birth outcomes, or adverse health outcomes of infants 1 year after birth.
Keywords
PCOShemolysis elevated liver enzymes and low plateletsSCCAI6-MMPTNF6-MethylmercaptopurineVentricular septum defect6-thioguanine nucleotidesMercaptopurineRespiratory syncytial 6-TGNTPMTAZAHBIVSDAORCORIBDIQRSGAazathioprinestandard deviationImmunomodulatorsCrohn’s diseaseInflammatory bowel diseaseThiopurine S-methyltransferaseThioguanineSmall for gestational ageRiskDrugpolycystic ovarian syndromebody mass indexBMIHarvey-Bradshaw IndexSide effectconfidence intervaltumor necrosis factorinterquartile rangeadjusted odds ratioCrude odds ratioodds ratioInfantNeonate
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Shannon L. Kanis, Alison de Lima-Karagiannis, Nanne K.H. de Boer, C. Janneke van der Woude,